--- title: "Polomar Health Services (PMHS) news: merger" url: "https://aibio.space/companies/polomar-health-services/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "PMHS merger news: Polomar Health ends its Altanine merger and a patent license. Polomar Health Services, Inc. (OTC: PMHS), United States." --- PMHS Polomar Health Services, Inc. OTC · United States # Polomar Health Services (PMHS) news PMHS merger news Company Updates · 2026-10-19 ## [Two Polomar Health directors resign, leaving three on the board](https://aibio.space/news/two-polomar-health-directors-resign-leaving-three-board/) Alexandra Peterson and Gabrielle Toledano resigned effective October 14, 2026, and the board reduced its size from five to three. The board has not decided whether to fill the vacancies. ## Latest Polomar Health Services news 1. 2026-07-15 Company Updates [Polomar Health names Douglas Beck chief financial officer](https://aibio.space/news/polomar-health-names-douglas-beck-chief-financial-officer/) Douglas Beck became chief financial officer and treasurer effective July 15, 2026, and serves as principal financial and accounting officer. He is a licensed certified public accountant. 2. 2026-07-06 Company Updates [Polomar Health reconstitutes its board and amends the equity plan](https://aibio.space/news/polomar-health-reconstitutes-board-amends-equity-plan/) Four directors were elected effective July 1, 2026, George Hornig became executive chairman and Terrence M. Tierney became interim chief executive officer. The annual evergreen increase falls from 10% to 3%. 3. 2026-06-15 Distress [Polomar Health ends its Altanine merger and a patent license](https://aibio.space/news/polomar-health-ends-altanine-merger-patent-license/) Polomar and Altanine terminated their merger agreement as of June 12, 2026, and ended a related patent license. Polomar has until September 7, 2026, to sell remaining inventory under that license. 4. 2026-05-15 Distress [Polomar Health waives Altanine merger conditions and amends CEO pact](https://aibio.space/news/polomar-health-waives-altanine-merger-conditions-amends-ceo-pact/) A May 11, 2026 consent and waiver letter sets aside several closing conditions and requires updated audited financial statements. A May 12 amendment cuts the chief executive's base salary to $19,000 a month. ## Polomar Health Services at a glance - **Ticker**: PMHS - **Listing**: OTC - **Country**: United States - **Cash, Mar 31, 2026**: $87,818 ### Related companies - [ENDONOVO THERAPEUTICS, INC.](https://aibio.space/companies/endonovo-therapeutics/) OTC: ENDV - [Personalis](https://aibio.space/companies/personalis/) NASDAQ: PSNL - [TFA Therapeutics](https://aibio.space/companies/tfa-therapeutics/) OTC: RAJAF - [SkinHealth Systems](https://aibio.space/companies/skinhealth-systems/) NASDAQ: SKIN - [MDxHealth SA](https://aibio.space/companies/mdxhealth/) NASDAQ: MDXH - [InMode](https://aibio.space/companies/inmode/) NASDAQ: INMD - [NOMAD POWER SOLUTIONS, INC.](https://aibio.space/companies/nomad-power-solutions/) NASDAQ: NMAD - [Opthea](https://aibio.space/companies/opthea/) OTC: CKDXF ### Also on OTC - [NIKA PHARMACEUTICALS, INC](https://aibio.space/companies/nika-pharmaceuticals/) NIKA - [ProText Mobility](https://aibio.space/companies/protext-mobility/) TXTM - [POSITRON CORP](https://aibio.space/companies/positron/) POSC - [Modern Mobility Aids](https://aibio.space/companies/modern-mobility-aids/) MDRM - [United Health Products](https://aibio.space/companies/united-health-products/) UEEC - [LUDWIG ENTERPRISES, INC.](https://aibio.space/companies/ludwig-enterprises/) LUDG ## What Polomar Health Services does Polomar Health Services, Inc. operates Polomar Specialty Pharmacy, LLC, a State of Florida licensed retail compounding pharmacy in Palm Harbor, Florida. The pharmacy is also licensed as a Special Sterile Compounding Pharmacy and operates under Sec. 503A of the Federal Food, Drug and Cosmetic Act, which allows it to compound drugs for prescriptions from state licensed physicians and other licensed healthcare professionals. The company is licensed to fulfill and deliver compounded prescribed medications in 28 states and is seeking authorization in other states. Before its September 30, 2024 merger with the pharmacy, the business concentrated on compounded dermatological prescription medications for topical delivery, used for conditions such as acne, alopecia areata, basal cell carcinoma, Becker's nevus and vitiligo. The pharmacy has also fulfilled a limited number of prescriptions for sterile compounded GLP-1 agonists for subcutaneous injection. Under a one-year non-exclusive pharmacy services agreement signed September 26, 2025, it fulfills GLP-1 agonist prescriptions for the network of on-line clinics operated by CareValidate, Inc. The company describes itself as a development stage company with a limited operating history and reports significant losses from operations. | Product or program | What it is | Stage | |---|---|---| | Polomar Pharmacy compounding | Retail and sterile compounding pharmacy filling prescriptions in 28 states | Licensed in 28 states | | Dermatological compounded formulations | Topical compounded medications for acne, alopecia areata, vitiligo and other skin conditions | | | Sterile compounded GLP-1 agonists | Sterile compounded GLP-1 agonists for subcutaneous injection | Fulfilled on a limited basis | | CareValidate pharmacy services | Fulfills GLP-1 agonist prescriptions for an online clinic network | Fulfilling since October 6, 2025 | Summarised from the company's [10-K filed May 6, 2026](https://www.sec.gov/Archives/edgar/data/1265521/000149315226021488/form10-k.htm). ## Polomar Health Services annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$648,231](https://www.sec.gov/Archives/edgar/data/1265521/000149315226021488/) | [$58,824](https://www.sec.gov/Archives/edgar/data/1265521/000149315226021488/) | | Net income (loss) | [-$10.7 million](https://www.sec.gov/Archives/edgar/data/1265521/000149315226021488/) | [-$1.3 million](https://www.sec.gov/Archives/edgar/data/1265521/000149315226021488/) | | Cash from operations | [-$395,995](https://www.sec.gov/Archives/edgar/data/1265521/000149315226021488/) | [-$1.0 million](https://www.sec.gov/Archives/edgar/data/1265521/000149315226021488/) | | Cash and equivalents | [$132,150](https://www.sec.gov/Archives/edgar/data/1265521/000149315226021488/) | [$6,191](https://www.sec.gov/Archives/edgar/data/1265521/000164117225012070/) | Latest balance sheet, Mar 31, 2026 (10-Q): cash and equivalents $87,818. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Polomar Health Services Is Polomar Health Services involved in a merger or acquisition? Our latest story on this, dated Jun 15, 2026: "Polomar Health ends its Altanine merger and a patent license". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/polomar-health-ends-altanine-merger-patent-license/). What is the ticker symbol of Polomar Health Services? Polomar Health Services, Inc. trades under the ticker PMHS on OTC. Where is Polomar Health Services listed? Polomar Health Services, Inc. is listed on OTC. Which country or territory is Polomar Health Services listed under? Our directory records Polomar Health Services, Inc. under United States. Does aibio.space cover Polomar Health Services? aibio.space lists Polomar Health Services, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What does Polomar Health Services develop? Polomar Health Services, Inc. operates Polomar Specialty Pharmacy, LLC, a State of Florida licensed retail compounding pharmacy in Palm Harbor, Florida. The pharmacy is also licensed as a Special Sterile Compounding Pharmacy and operates under Sec. What is Polomar Pharmacy compounding from Polomar Health Services? Polomar Pharmacy compounding: Retail and sterile compounding pharmacy filling prescriptions in 28 states Stage: Licensed in 28 states. What is Dermatological compounded formulations from Polomar Health Services? Dermatological compounded formulations: Topical compounded medications for acne, alopecia areata, vitiligo and other skin conditions Stage: Not stated. What was Polomar Health Services's revenue last year? $648,231 for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Polomar Health Services profitable? Polomar Health Services, Inc. reported a net loss of $10.7 million for the fiscal year ended Dec 31, 2025, and used $395,995 of cash in operations, per its annual report to the SEC. How much cash does Polomar Health Services have? $87,818 in cash at Mar 31, 2026, per its 10-Q. What is the latest Polomar Health Services (PMHS) stock news? Our latest story on Polomar Health Services, dated Oct 19, 2026: "Two Polomar Health directors resign, leaving three on the board". Alexandra Peterson and Gabrielle Toledano resigned effective October 14, 2026, and the board reduced its size from five to three. The board has not decided whether to fill the vacancies. [Source](https://aibio.space/news/two-polomar-health-directors-resign-leaving-three-board/). Is Polomar Health Services in financial distress? Our latest distress story, dated Jun 15, 2026: "Polomar Health ends its Altanine merger and a patent license". Polomar and Altanine terminated their merger agreement as of June 12, 2026, and ended a related patent license. Polomar has until September 7, 2026, to sell remaining inventory under that license. [Source](https://aibio.space/news/polomar-health-ends-altanine-merger-patent-license/). How can I follow Polomar Health Services (PMHS) news? Press Follow on this page to add Polomar Health Services to your Following list, or subscribe to the aibio.space newsletter. We have published 5 stories naming Polomar Health Services so far, in Company Updates, Distress. ## Investor discussion: Polomar Health Services Members talk about Polomar Health Services (PMHS). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Polomar Health Services, newest first. Each line links the filing it comes from. 1. 2026-08-14 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1265521/000149315226038324/form10-q.htm) 2. 2026-07-17 Legal Reported a change of independent auditor. SEC Form 8-K (Items 4.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1265521/000149315226033740/form8-k.htm) 3. 2026-06-15 Distress Reported the end of a material agreement. SEC Form 8-K (Items 1.02,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1265521/000149315226028687/form8-k.htm) 4. 2026-05-18 Distress Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. [Source](https://www.sec.gov/Archives/edgar/data/1265521/000149315226024128/formnt10-q.htm) 5. 2026-05-06 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1265521/000149315226021488/form10-k.htm) 6. 2026-04-29 Distress Reported the end of a material agreement. SEC Form 8-K (Items 1.02,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1265521/000149315226019659/form8-k.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:PMHS on TradingView](https://www.tradingview.com/symbols/OTC-PMHS/). ## Listing details Polomar Health Services, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker PMHS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Polomar Health Services, Inc. - **Ticker**: PMHS - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/polomar-health-services/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Polomar Health Services (PMHS) news: merger", 2026-10-31, https://aibio.space/companies/polomar-health-services/